Investment Banking

Taubman outfit takes lead on $4bn Novartis deal

PJT Partners leads Novartis's latest acquisition as healthcare dealmaking picks up the pace

Taubman outfit takes lead on $4bn Novartis deal

The independent advisory firm led by former Morgan Stanley investment banking boss Paul Taubman is advising Novartis on a $4bn acquisition — with an ex-head of M&A at the Swiss healthcare company taking the lead.

Novartis will offer $3.9bn in cash to buy Advanced Accelerator Applications, a French company listed in the US that works in molecular nuclear medicine theragnostics, which can be used in diagnosing and treating tumors and some types of cancer.

WSJ Logo
Bill Ackman’s Pro-Tennis Debut Lasted 67 MinutesExternal link

Bill Ackman’s Pro-Tennis Debut Lasted 67 Minutes